xzema
Research map, not medical advice. Talk to your doctor, especially for infants.
All treatments
STRONG EVIDENCE

Emollient/Moisturizer Therapy

Also discussed as: moisturizer, moisturiser, moisturizing, moisturising, moisturizer application, moisturizer use

Emollient therapy is recognized as a first-line treatment for managing skin barrier-related itch, including in children. Various emollients, such as ceramide creams, have shown efficacy in improving skin conditions associated with atopic dermatitis.
Evidence grade · papers only

STRONG EVIDENCE

23 level-I · 54 level-II · 12 level-IV · 7 level-VI · 6 level-III · 2 level-VII

Research base (design-resolved): 23 systematic review/meta-analysis, 54 randomized trials, 25 observational/descriptive.

Community interest · posts only

very high · 76,194 mentions

Most discussed for: topical_otc, topical_prescription, lifestyle_change

What the research says

Topical application of marshmallow ointment has demonstrated higher efficacy in children with AD than topical hydrocortisone.

Radhakrishnan et al. (2024), International Journal of Molecular Sciences. doi:10.3390/ijms25105375 · verified

Crisaborole reduces the occurrence of AD exacerbation.

Çetinarslan et al. (2023), Frontiers in Molecular Biosciences. doi:10.3389/fmolb.2023.1159404 · verified

Approved by the FDA for atopic dermatitis.

Tsuji et al. (2023), Biomedicines. doi:10.3390/biomedicines11051303 · verified

Topical application of a ceramide cream significantly ameliorated the severity of skin lesions after 4 weeks of treatment.

Ho et al. (2022), International Journal of Molecular Sciences. doi:10.3390/ijms23179697 · verified

One study even reported decreased S. aureus burden in patients after just a single application of a lotion containing antimicrobials isolated from human skin commensals.

Lunjani et al. (2021), Genes and Immunity. doi:10.1038/s41435-021-00133-9 · verified

Emollient therapy showed a trend towards a reduction in food sensitization. (n=100)

Brough et al. (2020), Allergy. doi:10.1111/all.14304 · verified

Emollients are the first-line therapy for the treatment of all skin barrier-related itch.

Yosipovitch et al. (2019), Acta Dermato Venereologica. doi:10.2340/00015555-3296 · verified

What the community reports

Experience reports, not evidence. Volumes from 1.1M triaged posts.

  • topical_otc
  • topical_prescription
  • lifestyle_change
  • other
  • traditional_medicine
  • environmental_change

Safety and side effects

Some safety concerns have been reported, including skin irritation and temporary itching. There is also a noted risk of skin infections in some cases.

For infants and children

Emollient therapy is approved for use in children, including infants aged 7-13 weeks.

Studied protocols

As reported in the papers, not recommendations.

dose: 2 mg/g; frequency: every other day; route: topical

Han et al. (2012), BMC Immunology

frequency: twice daily; route: topical; duration: from registration day to 28 weeks of age

Yamamoto‐Hanada et al. (2018), Clinical and Translational Allergy

route: topical

Tsuji et al. (2023), Biomedicines

dose: 1.5% w/w; frequency: twice daily (b.i.d.) or once daily (q.d.); route: topical; duration: 7 weeks for prophylactic treatment; 24 weeks for therapeutic treatment

Scuron et al. (2021), Frontiers in Immunology

frequency: once daily; route: topical; duration: 2 months

Bonzano et al. (2023), Biomolecules

dose: 0.1%; route: topical

Bonzano et al. (2023), Biomolecules

Drawn from 87 papers · generated 2026-06-11T12:40:11.096077+00:00 · phrasing by gpt-4o-mini, every number computed from the database and every citation machine-verified.